Antegrade radiofrequency ablation and stenting combined with endoscopic ultrasound-guided hepaticogastrostomy

Antegrade radiofrequency ablation and stenting combined with endoscopic ultrasound-guided hepaticogastrostomy - Antegrade radiofrequency ablation and stenting combined with endoscopic ultrasound-guided hepaticogastrostomy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033855

Enrollment

Registered

2018-08-22

Start date

2018-08-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unresectable malignant biliary obstruction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patient with unresectable malignant biliary obstruction which require biliary drainage 2) Patient having difficulty in transpapillary approach which require endoscopic ultrasound-guided approach

Exclusion criteria

Exclusion criteria: 1) Patients having difficulty in endoscopic ultrasound 2) Patients having difficulty in the puncture to the bile duct 3) Patients having difficulty in endoscopic RFA 4) Patients without informed consent 5) Inappropriate patients for entry on this study in the judgement of their research investigator

Design outcomes

Primary

Measure	Time frame
Technical success rate	—

Countries

Japan

Contacts

Public ContactTadahisa Inoue

Aichi Medical University Department of Gastroenterology

tinoue-tag@umin.ac.jp0561-62-3311

Outcome results